Frank Haluska, SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC (ARIA), sold 6,875 shares at $8.55 ($60K) on 2015-03-23, disclosed to the SEC on 2015-03-23.
Scheduled sale ($60k) by SVP, Clinical R&D, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.85 | 3,575 | $32K | 52.9% |
| 2 | $8.55 | 3,300 | $28K | 47.1% |
| Total | $8.71 avg | 6,875 | $60K | 100% |
| Filing → |
| ARIA | SELL | 2016-02-03 | $155K | — | Filing → |
| ARIA | SELL | 2015-09-28 | $36K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $38K | — | Filing → |